Transition Agreement and ReleaseTransition Agreement and Release • March 8th, 2019 • Selecta Biosciences Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 8th, 2019 Company Industry JurisdictionThis Transition Agreement and Release (“Agreement”) is made by and between John Leaman, M.D. (“Executive”) and Selecta Biosciences, Inc. (the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”) as of March 6, 2019 (the “Effective Date”). Capitalized terms used but not defined in this Agreement shall have the meanings set forth in the Employment Agreement (as defined below).